Eupraxia Pharmaceuticals Stock Market Value
| EPRX Stock | CAD 8.73 0.07 0.80% |
| Symbol | Eupraxia |
Eupraxia Pharmaceuticals Price To Book Ratio
Eupraxia Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Eupraxia Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Eupraxia Pharmaceuticals.
| 09/01/2025 |
| 11/30/2025 |
If you would invest 0.00 in Eupraxia Pharmaceuticals on September 1, 2025 and sell it all today you would earn a total of 0.00 from holding Eupraxia Pharmaceuticals or generate 0.0% return on investment in Eupraxia Pharmaceuticals over 90 days. Eupraxia Pharmaceuticals is related to or competes with Doman Building, Rogers Communications, E L, Intact Financial, Uniserve Communications, E L, and E L. Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and market... More
Eupraxia Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Eupraxia Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Eupraxia Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.44 | |||
| Information Ratio | 0.0778 | |||
| Maximum Drawdown | 21.42 | |||
| Value At Risk | (6.10) | |||
| Potential Upside | 6.91 |
Eupraxia Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Eupraxia Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Eupraxia Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Eupraxia Pharmaceuticals historical prices to predict the future Eupraxia Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0738 | |||
| Jensen Alpha | 0.3578 | |||
| Total Risk Alpha | 0.0091 | |||
| Sortino Ratio | 0.0888 | |||
| Treynor Ratio | 2.36 |
Eupraxia Pharmaceuticals Backtested Returns
Eupraxia Pharmaceuticals appears to be slightly risky, given 3 months investment horizon. Eupraxia Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0791, which denotes the company had a 0.0791 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Eupraxia Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please utilize Eupraxia Pharmaceuticals' Downside Deviation of 3.44, coefficient of variation of 1039.78, and Mean Deviation of 2.75 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Eupraxia Pharmaceuticals holds a performance score of 6. The firm shows a Beta (market volatility) of 0.16, which means not very significant fluctuations relative to the market. As returns on the market increase, Eupraxia Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Eupraxia Pharmaceuticals is expected to be smaller as well. Please check Eupraxia Pharmaceuticals' sortino ratio, maximum drawdown, and the relationship between the total risk alpha and treynor ratio , to make a quick decision on whether Eupraxia Pharmaceuticals' price patterns will revert.
Auto-correlation | 0.67 |
Good predictability
Eupraxia Pharmaceuticals has good predictability. Overlapping area represents the amount of predictability between Eupraxia Pharmaceuticals time series from 1st of September 2025 to 16th of October 2025 and 16th of October 2025 to 30th of November 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Eupraxia Pharmaceuticals price movement. The serial correlation of 0.67 indicates that around 67.0% of current Eupraxia Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.67 | |
| Spearman Rank Test | 0.53 | |
| Residual Average | 0.0 | |
| Price Variance | 0.35 |
Eupraxia Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Eupraxia Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Eupraxia Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Eupraxia Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Eupraxia Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Eupraxia Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Eupraxia Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Eupraxia Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Eupraxia Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Eupraxia Pharmaceuticals Lagged Returns
When evaluating Eupraxia Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Eupraxia Pharmaceuticals stock have on its future price. Eupraxia Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Eupraxia Pharmaceuticals autocorrelation shows the relationship between Eupraxia Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Eupraxia Pharmaceuticals.
Regressed Prices |
| Timeline |
Pair Trading with Eupraxia Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eupraxia Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eupraxia Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Eupraxia Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eupraxia Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eupraxia Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eupraxia Pharmaceuticals to buy it.
The correlation of Eupraxia Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eupraxia Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eupraxia Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eupraxia Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Eupraxia Stock
Eupraxia Pharmaceuticals financial ratios help investors to determine whether Eupraxia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eupraxia with respect to the benefits of owning Eupraxia Pharmaceuticals security.